Current Assets
Short- term Investments
Roivant Sciences Short- term Investments decreased by 5.9% to $2.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.3%, from $2.17B to $2.87B.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ3 2025
Last reportedQ1 2026
Metric ID:
current_assets_marketable_securities_currentHistorical Data
8 periods
| Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $3.43B | $3.16B | $2.17B | $3.26B | $3.15B | $3.05B | $2.87B |
| QoQ Change | — | — | -7.9% | -31.2% | +50.3% | -3.5% | -3.1% | -5.9% |
| YoY Change | — | — | — | — | — | -8.1% | -3.3% | +32.3% |
Range$0.00 – $3.43B
Avg YoY Growth+6.9%
Median YoY Growth-3.3%
Current Streak3 quarters decline
Short- term Investments at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's short- term investments?
- Roivant Sciences (ROIV) reported short- term investments of $2.87B in Q1 2026.
- How has Roivant Sciences's short- term investments changed year-over-year?
- Roivant Sciences's short- term investments increased by 32.3% year-over-year, from $2.17B to $2.87B.